Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Presentation THT 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 12, 2025

Presentation THT 2025

The Surgical Approach: Fix 'Em All At Once!

Presenter: Gilbert Tang

February 12, 2025

Presentation THT 2025

The Percutaneous Approach: One Step at a Time…

Presenter: Mark Reisman

February 12, 2025

Presentation THT 2025

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

Presenter: Ryan Tedford

February 12, 2025

Presentation THT 2025

SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli

Presenter: Howard Herrmann

February 12, 2025

Presentation THT 2025

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

Presenter: Torsten Vahl

February 12, 2025

Presentation THT 2025

TTVI Trial Updates

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

Putting It All Together: A Case of TTVR

Presenter: Karl-Philipp Rommel

February 12, 2025

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Presenter: Carolyn Lam

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Presenter: Jan Griffin

February 11, 2025

Presentation THT 2025

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Presenter: Ahmad Masri

February 11, 2025

Advertisement

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

The Surgical Approach: Fix 'Em All At Once!

The Percutaneous Approach: One Step at a Time…

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

TTVI Trial Updates

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Putting It All Together: A Case of TTVR

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content